These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 36629647)

  • 1. Immunoadsorption therapy in refractory heart failure patients with dilated cardiomyopathy: a potential therapeutic option.
    Cavusoglu Y; Tahmazov S; Murat S; Akay OM
    Rev Assoc Med Bras (1992); 2023; 69(1):90-96. PubMed ID: 36629647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of Cardiac Biomarkers for Monitoring Improvement of Left Ventricular Function by Immunoadsorption Treatment in Dilated Cardiomyopathy.
    Weinmann K; Werner J; Koenig W; Rottbauer W; Walcher D; Keßler M
    Biomolecules; 2019 Oct; 9(11):. PubMed ID: 31731547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunoadsorption therapy for dilated cardiomyopathy using tryptophan column-A prospective, multicenter, randomized, within-patient and parallel-group comparative study to evaluate efficacy and safety.
    Yoshikawa T; Baba A; Akaishi M; Wakabayashi Y; Monkawa T; Kitakaze M; Izumi T; Tomoike H
    J Clin Apher; 2016 Dec; 31(6):535-544. PubMed ID: 26801483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of protein A immunoadsorption in patients with advanced chronic dilated cardiomyopathy.
    Doesch AO; Konstandin M; Celik S; Kristen A; Frankenstein L; Hardt S; Goeser S; Kaya Z; Katus HA; Dengler TJ
    J Clin Apher; 2009; 24(4):141-9. PubMed ID: 19591221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic effect of immunoadsorption and subsequent immunoglobulin substitution in patients with dilated cardiomyopathy: Results from the observational prospective Bad Berka Registry.
    Ohlow MA; Brunelli M; Schreiber M; Lauer B
    J Cardiol; 2017 Feb; 69(2):409-416. PubMed ID: 27890513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation of plasma TSG-6 with cardiac function, myocardial fibrosis, and prognosis in dilated cardiomyopathy patients with heart failure.
    Xu L; Zhang Y; Kuang Y; Fang H; Ma Q
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2021 Jul; 46(7):689-696. PubMed ID: 34382584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical significance of troponin I efflux and troponin autoantibodies in patients with dilated cardiomyopathy.
    Miettinen KH; Eriksson S; Magga J; Tuomainen P; Kuusisto J; Vanninen EJ; Turpeinen A; Punnonen KR; Pettersson K; Peuhkurinen KJ
    J Card Fail; 2008 Aug; 14(6):481-8. PubMed ID: 18672196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Value of cardiopulmonary exercise test in cardiac function evaluation of patients with chronic left heart failure caused by dilated cardiomyopathy].
    Zhang W; Huang J; Xu H; Zhang S; Liu Z; Liao Z; Ma X; Liu Q
    Zhonghua Yi Xue Za Zhi; 2014 Apr; 94(14):1076-9. PubMed ID: 24851891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of Sacubitril/Valsartan vs Standard Medical Therapies on Plasma NT-proBNP Concentration and Submaximal Exercise Capacity in Patients With Heart Failure and Preserved Ejection Fraction: The PARALLAX Randomized Clinical Trial.
    Pieske B; Wachter R; Shah SJ; Baldridge A; Szeczoedy P; Ibram G; Shi V; Zhao Z; Cowie MR;
    JAMA; 2021 Nov; 326(19):1919-1929. PubMed ID: 34783839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and Safety of ARRY-371797 in
    MacRae CA; Taylor MRG; Mestroni L; Moses J; Ashley EA; Wheeler MT; Lakdawala NK; Hershberger RE; Sandor V; Saunders ME; Oliver C; Lee PA; Judge DP
    Circ Genom Precis Med; 2023 Feb; 16(1):e003730. PubMed ID: 36515663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcome and prognostic value of N-terminal pro-brain natriuretic peptide and high-sensitivity C-reactive protein in mildly dilated cardiomyopathy vs. dilated cardiomyopathy.
    Feng J; Tian P; Liang L; Chen Y; Wang Y; Zhai M; Huang Y; Zhou Q; Zhao X; Zhao L; Huang B; Huang L; Zhang Y; Zhang J
    ESC Heart Fail; 2022 Jun; 9(3):1625-1635. PubMed ID: 35243815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. REALM-DCM: A Phase 3, Multinational, Randomized, Placebo-Controlled Trial of ARRY-371797 in Patients With Symptomatic
    Garcia-Pavia P; Palomares JFR; Sinagra G; Barriales-Villa R; Lakdawala NK; Gottlieb RL; Goldberg RI; Elliott P; Lee P; Li H; Angeli FS; Judge DP; MacRae CA;
    Circ Heart Fail; 2024 Jul; 17(7):e011548. PubMed ID: 38979608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of intracoronary CD34+ stem cell transplantation in nonischemic dilated cardiomyopathy patients: 5-year follow-up.
    Vrtovec B; Poglajen G; Lezaic L; Sever M; Domanovic D; Cernelc P; Socan A; Schrepfer S; Torre-Amione G; Haddad F; Wu JC
    Circ Res; 2013 Jan; 112(1):165-73. PubMed ID: 23065358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adjunctive therapy with low-molecular-weight heparin in patients with chronic heart failure secondary to dilated cardiomyopathy: one-year follow-up results of the randomized trial.
    Wojnicz R; Nowak J; Szyguła-Jurkiewicz B; Wilczek K; Lekston A; Trzeciak P; Nowalany-Kozielska E; Zembala M; Wodniecki J; Poloński L
    Am Heart J; 2006 Oct; 152(4):713.e1-7. PubMed ID: 16996844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Add-on Immunoadsorption Shortly-after Optimal Medical Treatment Further Significantly and Persistently Improves Cardiac Function and Symptoms in Recent-Onset Heart Failure-A Single Center Experience.
    Weinmann K; Werner J; Koenig W; Rottbauer W; Walcher D; Keßler M
    Biomolecules; 2018 Nov; 8(4):. PubMed ID: 30400209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential role of autoantibodies belonging to the immunoglobulin G-3 subclass in cardiac dysfunction among patients with dilated cardiomyopathy.
    Staudt A; Böhm M; Knebel F; Grosse Y; Bischoff C; Hummel A; Dahm JB; Borges A; Jochmann N; Wernecke KD; Wallukat G; Baumann G; Felix SB
    Circulation; 2002 Nov; 106(19):2448-53. PubMed ID: 12417541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Outcomes of Autologous Stem Cell-Patch Implantation for Patients With Heart Failure With Nonischemic Dilated Cardiomyopathy.
    Domae K; Miyagawa S; Yoshikawa Y; Fukushima S; Hata H; Saito S; Kainuma S; Kashiyama N; Iseoka H; Ito E; Harada A; Takeda M; Sakata Y; Toda K; Pak K; Yamada T; Sawa Y
    J Am Heart Assoc; 2021 Jul; 10(13):e008649. PubMed ID: 34212772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of Repetitive Transendocardial CD34
    Vrtovec B; Poglajen G; Sever M; Zemljic G; Frljak S; Cerar A; Cukjati M; Jaklic M; Cernelc P; Haddad F; Wu JC
    Circ Res; 2018 Jul; 123(3):389-396. PubMed ID: 29880546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute hemodynamic effects during immunoadsorption in patients with dilated cardiomyopathy positive for beta 1-adrenoceptor autoantibodies.
    Christ T; Dobrev D; Wallukat G; Schüler S; Ravens U
    Methods Find Exp Clin Pharmacol; 2001 Apr; 23(3):141-4. PubMed ID: 11523313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in natriuretic peptides following passive containment surgery in heart failure patients with dilated cardiomyopathy.
    Bredin F; Liska J; Franco-Cereceda A
    Interact Cardiovasc Thorac Surg; 2009 Feb; 8(2):191-4. PubMed ID: 19008326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.